175 related articles for article (PubMed ID: 17143944)
1. Endoscopic biliary drainage for patients with unresectable pancreatic cancer with obstructive jaundice who are to undergo gemcitabine chemotherapy.
Takasawa O; Fujita N; Kobayashi G; Noda Y; Ito K; Horaguchi J
World J Gastroenterol; 2006 Dec; 12(45):7299-303. PubMed ID: 17143944
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of metallic stents in patients with unresectable pancreatic cancer receiving gemcitabine.
Nakai Y; Isayama H; Kawabe T; Tsujino T; Yoshida H; Sasaki T; Tada M; Arizumi T; Yagioka H; Kogure H; Togawa O; Ito Y; Matsubara S; Hirano K; Sasahira N; Omata M
Pancreas; 2008 Nov; 37(4):405-10. PubMed ID: 18953253
[TBL] [Abstract][Full Text] [Related]
3. [Two cases of advanced pancreatic cancer responding to gemcitabine with long survival of 2 years].
Yajima T; Furukawa Y; Ishii Y; Hattori Y; Matsumoto N; Yamamoto M; Yamaoka Y; Fujihara M; Fujita M; Kuniki H
Gan To Kagaku Ryoho; 2004 Jun; 31(6):953-7. PubMed ID: 15222120
[TBL] [Abstract][Full Text] [Related]
4. Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinoma.
Isayama H; Tsujino T; Nakai Y; Sasaki T; Nakagawa K; Yamashita H; Aoki T; Koike K
World J Gastroenterol; 2012 May; 18(19):2364-70. PubMed ID: 22654427
[TBL] [Abstract][Full Text] [Related]
5. Stent patency using competing risk model in unresectable pancreatic cancers inserted with biliary self-expandable metallic stent.
Eum YO; Kim YT; Lee SH; Park SW; Hwang JH; Yoon WJ; Ryu JK; Yoon YB; Han JK; Yoon CJ; Cho JH; Choi Y
Dig Endosc; 2013 Jan; 25(1):67-75. PubMed ID: 23286259
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of S100A4 mRNA in EUS-FNA specimens for the assessment of chemosensitivity to gemcitabine from patients with unresectable pancreatic cancer.
Ma G; Sun Y; Fu S
Int J Clin Exp Pathol; 2015; 8(10):13284-8. PubMed ID: 26722531
[TBL] [Abstract][Full Text] [Related]
7. Effect of low-dose gemcitabine on unresectable pancreatic cancer in elderly patients.
Matsumoto K; Miyake Y; Kato H; Kawamoto H; Imagawa A; Toyokawa T; Nakatsu M; Ando M; Hirohata M; Yamamoto K
Digestion; 2011; 84(3):230-5. PubMed ID: 21860243
[TBL] [Abstract][Full Text] [Related]
8. [Long-term survival of a patient with locally advanced unresectable pancreatic cancer treated with gemcitabine after chemoradiation therapy].
Chohno T; Aoki T; Hyuga S; Watanabe R; Matsumoto T; Takemoto H; Takachi K; Nishioka K; Uemura Y; Kobayashi K
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1881-3. PubMed ID: 24393953
[TBL] [Abstract][Full Text] [Related]
9. A novel combination of percutaneous stenting with iodine-125 seed implantation and chemotherapy for the treatment of pancreatic head cancer with obstructive jaundice.
Chi Z; Chen L; Huang J; Jiang N; Zheng Q; Huang N; Yang W
Brachytherapy; 2021; 20(1):218-225. PubMed ID: 33158777
[TBL] [Abstract][Full Text] [Related]
10. Self-expandable metallic stents vs. plastic stents for endoscopic biliary drainage in hepatocellular carcinoma.
Chung KH; Lee SH; Park JM; Lee JM; Ahn DW; Ryu JK; Kim YT
Endoscopy; 2015 Jun; 47(6):508-16. PubMed ID: 25590179
[TBL] [Abstract][Full Text] [Related]
11. Successful adjuvant bi-weekly gemcitabine chemotherapy for pancreatic cancer without impairing patients' quality of life.
Toyama Y; Yoshida S; Saito R; Kitamura H; Okui N; Miyake R; Ito R; Son K; Usuba T; Nojiri T; Yanaga K
World J Surg Oncol; 2013 Jan; 11():3. PubMed ID: 23302293
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous stenting and chemotherapy for unresectable pancreatic cancer: Comparison of irradiation stents vs conventional metal stents.
Wang W; Li P; Wang Y; Liu B; Li Y
Pancreatology; 2019 Oct; 19(7):957-962. PubMed ID: 31551162
[TBL] [Abstract][Full Text] [Related]
13. [Locally advanced pancreatic cancer that enlarged after administration of gemcitabine and responded to oral TS-1--a case report].
Tanaka S; Fujii M; Goubaru M; Ohta T; Ogata M; Makino Y
Gan To Kagaku Ryoho; 2005 Oct; 32(10):1485-7. PubMed ID: 16227755
[TBL] [Abstract][Full Text] [Related]
14. [Usefulness of gemcitabine in the treatment of advanced pancreatic cancer in terms of its clinical benefits].
Shiozawa S; Tsuchiya A; Kumazawa K; Ogawa K
Gan To Kagaku Ryoho; 2003 Apr; 30(4):483-7. PubMed ID: 12722678
[TBL] [Abstract][Full Text] [Related]
15. Gemcitabine and S-1 combination chemotherapy versus gemcitabine alone for locally advanced and metastatic pancreatic cancer: a meta-analysis of randomized controlled trials in Asia.
Li Y; Sun J; Jiang Z; Zhang L; Liu G
J Chemother; 2015 Aug; 27(4):227-34. PubMed ID: 25790948
[TBL] [Abstract][Full Text] [Related]
16. Gemcitabine as first-line chemotherapy in elderly patients with unresectable pancreatic carcinoma.
Yamagishi Y; Higuchi H; Izumiya M; Sakai G; Iizuka H; Nakamura S; Adachi M; Hozawa S; Takaishi H; Hibi T
J Gastroenterol; 2010 Nov; 45(11):1146-54. PubMed ID: 20549255
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of gemcitabine-based chemotherapy on advanced pancreatic cancer].
Gong JF; Zhang XD; Li J; Di LJ; Jin ML; Shen L
Ai Zheng; 2007 Aug; 26(8):890-4. PubMed ID: 17697554
[TBL] [Abstract][Full Text] [Related]
18. Gemcitabine as palliative treatment in patients with unresectable pancreatic cancer previously treated with placement of a covered metal stent. A randomized controlled trial.
Xinopoulos D; Dimitroulopoulos D; Karanikas I; Fotopoulou A; Oikonomou N; Korkolis D; Kouroumalis E; Antsaklis G; Vassilopoulos P; Paraskevas E
J BUON; 2008; 13(3):341-7. PubMed ID: 18979547
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of endoscopic biliary stenting for obstructive jaundice caused by hepatocellular carcinoma.
Sugiyama G; Okabe Y; Ishida Y; Saitou F; Kawahara R; Ishikawa H; Horiuchi H; Kinoshita H; Tsuruta O; Sata M
World J Gastroenterol; 2014 Jun; 20(22):6968-73. PubMed ID: 24944490
[TBL] [Abstract][Full Text] [Related]
20. Covered self-expandable metal stents versus plastic stents for preoperative biliary drainage in patient receiving neo-adjuvant chemotherapy for borderline resectable pancreatic cancer: Prospective randomized study.
Tamura T; Itonaga M; Ashida R; Yamashita Y; Hatamaru K; Kawaji Y; Emori T; Kitahata Y; Miyazawa M; Hirono S; Okada KI; Kawai M; Shimokawa T; Yamaue H; Kitano M
Dig Endosc; 2021 Nov; 33(7):1170-1178. PubMed ID: 33410564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
